Bo Kong

4.2k total citations · 1 hit paper
98 papers, 3.2k citations indexed

About

Bo Kong is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Bo Kong has authored 98 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 39 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Bo Kong's work include Drug Transport and Resistance Mechanisms (32 papers), Liver Disease Diagnosis and Treatment (18 papers) and Fibroblast Growth Factor Research (16 papers). Bo Kong is often cited by papers focused on Drug Transport and Resistance Mechanisms (32 papers), Liver Disease Diagnosis and Treatment (18 papers) and Fibroblast Growth Factor Research (16 papers). Bo Kong collaborates with scholars based in United States, China and Germany. Bo Kong's co-authors include Grace L. Guo, John Y.L. Chiang, Li Wang, Curtis D. Klaassen, Youcai Zhang, James P. Luyendyk, Ossama Tawfik, Ann Thomas, Jessica A. Williams and Daniel Rizzolo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Bo Kong

96 papers receiving 3.2k citations

Hit Papers

Mechanism of tissue-specific farnesoid X receptor in supp... 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Kong United States 32 1.4k 1.2k 1.2k 883 478 98 3.2k
Tadashi Ikegami Japan 28 962 0.7× 846 0.7× 743 0.6× 880 1.0× 556 1.2× 110 2.7k
Yanqiao Zhang United States 24 1.1k 0.8× 1.1k 0.8× 703 0.6× 691 0.8× 216 0.5× 50 2.5k
Yingqun Zhou China 37 1.4k 1.0× 919 0.7× 456 0.4× 500 0.6× 675 1.4× 92 3.3k
Tian Lan China 38 2.3k 1.7× 920 0.7× 587 0.5× 487 0.6× 565 1.2× 134 4.5k
Francisco Javier Cubero Spain 32 937 0.7× 1.3k 1.0× 336 0.3× 404 0.5× 793 1.7× 90 2.9k
Guobin He United States 15 1.7k 1.3× 1.1k 0.9× 1.1k 0.9× 251 0.3× 630 1.3× 25 4.0k
Masaki Kato Japan 26 679 0.5× 1.4k 1.1× 316 0.3× 442 0.5× 560 1.2× 84 2.4k
Shuichi Seki Japan 28 942 0.7× 1.4k 1.1× 317 0.3× 581 0.7× 1.3k 2.7× 129 3.4k
Benjamin L. Woolbright United States 28 915 0.7× 857 0.7× 628 0.5× 608 0.7× 728 1.5× 64 2.8k
Dahn L. Clemens United States 27 733 0.5× 976 0.8× 344 0.3× 312 0.4× 193 0.4× 73 2.4k

Countries citing papers authored by Bo Kong

Since Specialization
Citations

This map shows the geographic impact of Bo Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Kong more than expected).

Fields of papers citing papers by Bo Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Kong. The network helps show where Bo Kong may publish in the future.

Co-authorship network of co-authors of Bo Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Kong. A scholar is included among the top collaborators of Bo Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Kong. Bo Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Bo, Ill Yang, Anita Brinker, et al.. (2024). Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model. Toxicological Sciences. 202(2). 179–195. 2 indexed citations
2.
Meadows, Vik, Peihong Zhou, Laurie B. Joseph, et al.. (2024). Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model. Toxicological Sciences. 199(2). 316–331. 6 indexed citations
3.
Yang, Na, Bo Kong, Fei Huang, et al.. (2023). Recent advances in targeted protein degraders as potential therapeutic agents. Molecular Diversity. 28(1). 309–333. 23 indexed citations
4.
Wang, Lixue, Guosheng Wang, Wenjun Mao, et al.. (2023). Bioinspired engineering of fusogen and targeting moiety equipped nanovesicles. Nature Communications. 14(1). 3366–3366. 45 indexed citations
5.
Yu, Huan, et al.. (2023). Spatial heterogeneity and attribution analysis of gravel particle size in northern Tibet Plateau. Environmental Science and Pollution Research. 30(21). 60268–60281. 2 indexed citations
6.
Kong, Bo, et al.. (2023). Intrinsic point defects and the n- and p-type dopability in α- and β-Bi2O3 photocatalysts. Physical Chemistry Chemical Physics. 25(20). 14417–14429. 15 indexed citations
8.
Kong, Bo, et al.. (2022). Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice. Liver Research. 6(2). 84–92. 2 indexed citations
9.
Li, Hongzhen, Chunyan Peng, Xiwei Ding, et al.. (2022). PPARγ/SOD2 Protects Against Mitochondrial ROS-Dependent Apoptosis via Inhibiting ATG4D-Mediated Mitophagy to Promote Pancreatic Cancer Proliferation. Frontiers in Cell and Developmental Biology. 9. 745554–745554. 15 indexed citations
10.
Rizzolo, Daniel, Bo Kong, Anita Brinker, et al.. (2021). Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1. Acta Pharmaceutica Sinica B. 11(12). 3847–3856. 69 indexed citations
11.
Huang, Mingxing, Bo Kong, Min Zhang, et al.. (2020). Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency. Laboratory Investigation. 100(9). 1158–1168. 30 indexed citations
12.
Nikonorova, Inna A., Qiaoqiao Zhu, Emily T. Mirek, et al.. (2019). Age modulates liver responses to asparaginase-induced amino acid stress in mice. Journal of Biological Chemistry. 294(38). 13864–13875. 5 indexed citations
13.
Kong, Bo, Mingxing Huang, Monica D. Chow, et al.. (2018). A novel fibroblast growth factor 15-dependent and bile acid-independent promotion of liver regeneration in mice. Cancer Biology and Medicine. 15. 6. 1 indexed citations
14.
Guo, Grace L., Bo Kong, Susan C. Hubchak, et al.. (2018). Farnesoid X receptor signaling activates the hepatic X‐box binding protein 1 pathway in vitro and in mice. Hepatology. 68(1). 304–316. 33 indexed citations
15.
Schumacher, Justin D., Bo Kong, Yi Pan, et al.. (2017). The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. Toxicology and Applied Pharmacology. 330. 1–8. 41 indexed citations
16.
Byun, Sangwon, Young‐Chae Kim, Yang Zhang, et al.. (2017). A postprandial FGF 19‐ SHPLSD 1 regulatory axis mediates epigenetic repression of hepatic autophagy. The EMBO Journal. 36(12). 1755–1769. 60 indexed citations
17.
Yu, Huan, et al.. (2012). Advances in the Study of Evapotranspiration of Regional Land Surface Based on Remote Sensing Technology. Guotu ziyuan yaogan. 24(1). 1–7. 3 indexed citations
18.
Li, Guodong, Ann Thomas, Jessica A. Williams, et al.. (2012). Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding. PLoS ONE. 7(4). e35895–e35895. 36 indexed citations
19.
Kong, Bo, Iván L. Csanaky, Lauren M. Aleksunes, et al.. (2012). Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity. Toxicology and Applied Pharmacology. 261(2). 189–195. 15 indexed citations
20.
Weir, Matthew R., Jeremy Wright, Keith C. Ferdinand, et al.. (1993). Comparison of the efficacy and metabolic effects of nicardipine and hydrochlorothiazide in hypertensive black men and women.. PubMed. 7(2). 141–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026